EMILY SNYDER: Open Payments
NPI 1639879067 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 22 payments from 12 companies in 2025. Trend: 2023 $151 · 2024 $560 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $200 |
| Novartis Pharmaceuticals Corporation | 7 | $120 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Kestra Medical Technology Services, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $27 |
| Philips North America LLC | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: DAXXIFY, LEQVIO, AMVUTTRA, Assure WCD, Wegovy, ECC Solutions, VYNDAQEL, Kerendia.
Industry payments across FL — which companies pay providers there.
